Sotera Health (NASDAQ:SHC) Director Gtcr Investment Xi Llc Sells 10,000,000 Shares

Sotera Health (NASDAQ:SHC) Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the transaction, the director now owns 49,215,301 shares in the company, valued at $739,705,974.03. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

Sotera Health Stock Up 7.3 %

NASDAQ SHC traded up $1.15 during trading on Monday, reaching $16.80. The company’s stock had a trading volume of 8,129,105 shares, compared to its average volume of 1,380,471. The business has a 50-day moving average price of $13.92 and a 200-day moving average price of $12.76. Sotera Health has a 1-year low of $10.71 and a 1-year high of $17.44. The stock has a market capitalization of $4.76 billion, a PE ratio of 89.22 and a beta of 2.06. The company has a current ratio of 2.93, a quick ratio of 2.59 and a debt-to-equity ratio of 5.46.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Monday, August 5th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.15 by $0.04. The business had revenue of $277.00 million during the quarter, compared to analyst estimates of $266.45 million. Sotera Health had a net margin of 3.65% and a return on equity of 47.26%. Sotera Health’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.19 EPS. On average, research analysts forecast that Sotera Health will post 0.64 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the stock. Sanctuary Advisors LLC acquired a new position in shares of Sotera Health during the second quarter worth approximately $130,000. Brandes Investment Partners LP raised its stake in Sotera Health by 301.3% during the 2nd quarter. Brandes Investment Partners LP now owns 56,429 shares of the company’s stock valued at $670,000 after purchasing an additional 42,367 shares during the last quarter. Algert Global LLC bought a new stake in Sotera Health in the 2nd quarter valued at $169,000. Clearline Capital LP bought a new stake in Sotera Health in the 2nd quarter valued at $1,707,000. Finally, Sessa Capital IM L.P. grew its position in Sotera Health by 7.5% in the 2nd quarter. Sessa Capital IM L.P. now owns 4,300,597 shares of the company’s stock worth $51,048,000 after purchasing an additional 300,597 shares during the last quarter. 91.03% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

SHC has been the topic of a number of research analyst reports. Barclays lifted their price target on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a report on Tuesday, August 6th. Piper Sandler began coverage on shares of Sotera Health in a research note on Tuesday, May 21st. They issued a “neutral” rating and a $13.00 price objective on the stock. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research note on Tuesday, August 6th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $15.70.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.